Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiannao Capsule is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanghai Pharmaceuticals Group Qingdao Growful Pharmaceutical. It is formulated as an oral capsule containing a blend of botanical extracts, typically including *Ziziphus jujuba* var. *spinosa* (sour jujube seed), *Angelica sinensis*, *Dioscorea opposita* (Chinese yam), and other herbal ingredients. The product is primarily indicated for the treatment of neurasthenia, insomnia, forgetfulness, and dizziness, which are traditionally attributed to a deficiency of the heart and kidney in TCM theory. It is marketed as an over-the-counter (OTC) medication in China and is intended to nourish the blood, calm the spirit, and improve cognitive health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiannao Capsule.